GFAP and epilepsy: Our study also demonstrated that inhibiting miR-103a expression can inhibit the activation of astrocytes in epilepsy rats, which is reflected by the results that the mRNA and protein expression of GFAP were significantly lower in the EP + miR-103a inhibitors group.